ArticleThe Journal of pathology2020

Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.

Rachel Barrow-McGee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.